(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.01%) $82.62
(0.74%) $2.05
(-0.55%) $2 344.70
(-1.01%) $27.38
(-0.36%) $958.00
(0.06%) $0.933
(0.08%) $10.99
(0.02%) $0.796
(0.01%) $93.31
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 5.01%
-1.65% $ 27.40
@ $27.68
Ausgestellt: 14 Feb 2024 @ 21:25
Rendite: -1.01%
Vorheriges Signal: Feb 14 - 17:01
Vorheriges Signal:
Rendite: -0.29 %
Live Chart Being Loaded With Signals
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally...
Stats | |
---|---|
Tagesvolumen | 399 329 |
Durchschnittsvolumen | 572 395 |
Marktkapitalisierung | 1.26B |
EPS | $0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-04-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -60.89 |
ATR14 | $0.0330 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Manley Corey J | Sell | 83 | Common Stock |
2024-03-15 | Spears Joseph Brian | Sell | 56 | Common Stock |
2024-02-27 | Manley Corey J | Buy | 31 965 | Common Stock |
2024-02-27 | Etta Nchacha | Buy | 37 853 | Common Stock |
2024-02-27 | Lipps Randall A | Buy | 107 251 | Common Stock |
INSIDER POWER |
---|
61.03 |
Last 96 transactions |
Buy: 375 105 | Sell: 205 180 |
Volumen Korrelation
Omnicell Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Omnicell Inc Korrelation - Währung/Rohstoff
Omnicell Inc Finanzdaten
Annual | 2023 |
Umsatz: | $1.15B |
Bruttogewinn: | $499.93M (43.58 %) |
EPS: | $-0.450 |
FY | 2023 |
Umsatz: | $1.15B |
Bruttogewinn: | $499.93M (43.58 %) |
EPS: | $-0.450 |
FY | 2022 |
Umsatz: | $1.30B |
Bruttogewinn: | $588.99M (45.45 %) |
EPS: | $0.130 |
FY | 2021 |
Umsatz: | $1.13B |
Bruttogewinn: | $554.65M (49.00 %) |
EPS: | $1.784 |
Financial Reports:
No articles found.
Omnicell Inc
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.